147 related articles for article (PubMed ID: 9661820)
1. Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania.
van den Broek J; Mfinanga S; Moshiro C; O'Brien R; Mugomela A; Lefi M
Int J Tuberc Lung Dis; 1998 Jul; 2(7):547-52. PubMed ID: 9661820
[TBL] [Abstract][Full Text] [Related]
2. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
3. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi.
Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM
Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250
[TBL] [Abstract][Full Text] [Related]
4. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
[TBL] [Abstract][Full Text] [Related]
5. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
[TBL] [Abstract][Full Text] [Related]
6. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of HIV-associated tuberculosis in rural Cambodia.
Cain KP; Kanara N; Laserson KF; Vannarith C; Sameourn K; Samnang K; Qualls ML; Wells CD; Varma JK
Int J Tuberc Lung Dis; 2007 Sep; 11(9):1008-13. PubMed ID: 17705980
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
10. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
[TBL] [Abstract][Full Text] [Related]
11. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
[TBL] [Abstract][Full Text] [Related]
12. Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa.
Winqvist N; Nauclér A; Gomes V; Djamanca I; Koivula T; Jensen H; Dias F; Biberfeld G; Källenius G; Norberg R
Int J Tuberc Lung Dis; 2000 Sep; 4(9):845-52. PubMed ID: 10985653
[TBL] [Abstract][Full Text] [Related]
13. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
[TBL] [Abstract][Full Text] [Related]
14. Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients.
Pulido F; Peña JM; Rubio R; Moreno S; González J; Guijarro C; Costa JR; Vázquez JJ
Arch Intern Med; 1997 Jan; 157(2):227-32. PubMed ID: 9009982
[TBL] [Abstract][Full Text] [Related]
15. Impact of the human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991-1995.
Connolly C; Davies GR; Wilkinson D
Int J Tuberc Lung Dis; 1998 Nov; 2(11):919-25. PubMed ID: 9848614
[TBL] [Abstract][Full Text] [Related]
16. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
[TBL] [Abstract][Full Text] [Related]
17. Current status of treatment completion and fatality among tuberculosis patients in Spain.
Caylà JA; Caminero JA; Rey R; Lara N; Vallés X; Galdós-Tangüis H;
Int J Tuberc Lung Dis; 2004 Apr; 8(4):458-64. PubMed ID: 15141739
[TBL] [Abstract][Full Text] [Related]
18. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
Dheda K; Lampe FC; Johnson MA; Lipman MC
J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
[TBL] [Abstract][Full Text] [Related]
19. Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection.
Kwara A; Roahen-Harrison S; Prystowsky E; Kissinger mR; Adams R; Mathison J; Hyslop NE
Int J Tuberc Lung Dis; 2005 May; 9(5):485-93. PubMed ID: 15875918
[TBL] [Abstract][Full Text] [Related]
20. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis.
Jeon DS; Kim DH; Kang HS; Hwang SH; Min JH; Kim JH; Sung NM; Carroll MW; Park SK
Int J Tuberc Lung Dis; 2009 May; 13(5):594-600. PubMed ID: 19383192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
